newly issued shares which offering to the specific investor on a private placement basis and has a strong financial status. Therefore, this capital increase will help to support the Company’s financial

also result in an appropriate capital structure and financial ratio that could be fairly compared to peers in the same industry as well as support the investment in current and future projects. On 26

period of 2 0 1 7 as driven mainly by rising expenses on office employees, office and miscellaneous expenses and depreciation and amortization expenses to support more workloads and more units from

associate. This resulted in a decrease in basic earnings per share from Bt1.72 for 2018 to Bt0.80 for 2019. Total Asset Total assets as of December 31, 2019, amounted to Bt16,501 million, consisting of

20.64 - 0.00% Retained earnings 74.52 80.98 (6.46) (7.98%) Other component of equity 81.85 1.07 80.78 7,549.53% Total parent’s equity 882.54 808.22 74.32 9.20% Non-controlling interests 314.36 80.62

hospitals and medical equipment that will support continuous growth momentum in demand for medical devices in Thailand. 4 Due to growth medical device business, the Company plans to develop new products as

) -45% 10% Profit attributable to owners of parent 1,168 (1,546) 214 -82% 114% Basic earnings per share (Baht) 0.85 (1.12) 0.16 Note: 1/ EBITDA from Refinery Business of the Company, BCP Trading Pte. Ltd

Profit (Loss) (16.93) (2.20) 14.73 669.55 Earnings per share (Baht per share) (0.0032) (0.0005) 0.0027 540.00 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of 16.93

expenses of 9.89% year on year was derived from higher employee expenses to support more workloads and more units from business expansion of the Company and its subsidiaries. Table 8: Administrative Expenses

employee expenses to support more workloads and more units as well as rising depreciation and amortization expenses Table 9 : Administrative Expenses by Type of Expenses for the Three Months Period Ended 30